Nutritional management of cystic fibrosis in children;Prise en charge nutritionnelle de la mucoviscidose a l'age pediatrique

Archives de Pediatrie

Volumn 7, Issue 4, 2000, Pages 396-401

  Munck, A ^a   Navarro, J ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Cystic fibrosis; Energy requirements; Enteral feeding

Indexed keywords

KREON; PANCREAS EXTRACT; PANCRELIPASE;

CHILD GROWTH; CYSTIC FIBROSIS; DISEASE SEVERITY; ENERGY EXPENDITURE; ENTERIC FEEDING; GASTROSTOMY; HUMAN; MALNUTRITION; NUTRITIONAL STATUS; REVIEW; SURVIVAL TIME;

EID: 0034177164     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(00)88836-3     Document Type: Article

References (26)

1. 1 Corey M, Laughlin FJ, Williams M, Levison H. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988 ; 41 : 583-91.
2. 2 MacDonald A. Nutritional management of cystic fibrosis. Arch Dis Child 1996 ; 74 : 81-7.
3. 3 Prise en charge nutritionnelle dans la mucoviscidose. Comité de nutrition. Société française de pédiatrie. Arch Fr Pédiatr 1991 ; 48 : 295-7.
4. 4 Munck A, le Bourgeois M, Gerardin M, Navarro J. Mucoviscidose : diététique et support nutritionnel. Nutr Clin Métabol 1998 ; 12 : 283-8.
5. 5 O'Rawe A, McIntosh I, Dodge A, Brock DJ, Redmond AO, Ward R, et al. Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clin Soc 1992 ; 82 : 71-6.
6. 6 Heijerman HG, Lamers CB, Dijkman JH, Bakker W. Ranitidine compared with dimethylprostaglandin E2 - analogue enprostil as adjunct to pancreatic enzyme replacement in adult cystic fibrosis. Scand J Gastroenterol 1990 ; 25 : 26-31.
7. 7 Smyth RL, Velzen DR, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. Lancet 1994 ; 343 : 85-6.
8. 8 Lebenthal E. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better". J Pediatr Gastroenterol Nutr 1994 ; 18 : 423-5.
9. 9 Lenoir G, Silly C, Brousse N, Cezard JP, Navarro J. The management of cystic fibrosis with enzymes in France, consensus conference on the management of cystic fibrosis. New York, Berlin, Heidelberg: Springer Verlag; 1995. p. 7-12.
10. 10 Nasr SZ, O'Leary MH, Hillermeier C, Laxova A, Carey PM, Langhough R, et al. Correction of vitamin E deficiency with fat soluble versus water-miscible preparations of vitamin E in patients with cystic fibrosis. J Pediatr 1993 ; 122 : 810-2.
11. 11 Marcus MS, Sondel SA, Farrell PM, Laxova A, Carey PM, Langhough R, et al. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr 1991 ; 54 : 578-82.
12. 12 Farrell PM, Mischler EH, Engle MJ, Brown DJ, Laus M. Fatty acid abnormalites in cystic fibrosis. Pediatr Res 1985 ; 19 : 104-9.
13. 13 Strandvik B. Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis. Acta Paediatr Scand 1989 ; Suppl 363 : 58-65.
14. 14 Koletzko B, Rühl-Bagheri IB, Thiel I, Steinkamp G. Effects of a formul rich in linoleic acid on essential fatty acid status of cystic fibrosis patients. Clin Nutr 1992 ; 11 : 39-40.
15. 15 Henderson WR, Astley SJ, McCready M, Kushmerick P, Casey S, Becker J, et al. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. J Pediatr 1994 ; 124 : 400-8.
16. 16 Cartwright-Shamoon JM, Dodge JA. Free fatty acids: selectively modulation transport in rat intestine [Abstract]. Pediatr Pulmon 1992 ; 8 Suppl : 271 A.
17. 17 Maherzi A, Ategbo S, Pharaon I, Munck A, Cezard JP, Foucaud P, et al. Application clinique de la mesure de la différence de potentiel transépithéliale nasale dans la mucoviscidose. Presse Méd 1995 ; 24 : 437-40.
18. 18 Vic P, Tassin E, Turck D, Gottrand F, Launay V, Farriaux JP. Fréquence du reflux gastro-œsophagien chez le nourrisson et le jeune enfant atteint de mucoviscidose. Arch Pédiatr 1995 ; 2 : 742-6.
19. 19 Stark LJ, Jelalian E, Mulvihill MM, Powers SW, Bowen AM, Spieh LE, et al. Eating in preschool children with cystic fibrosis and healthy peers: behavioral anlysis. Pediatrics 1995 ; 95 : 210-5.
20. 20 Arrigo T, Cucinotta D, Conti Nibali S, Di Cesare E, Di Benedetto A, Magazzu G, et al. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two year follow-up. Acta Paediatr 1993 ; 82 : 249-53.
21. 21 Stark LJ, Mulvihill MM, Powers S, Jelalian E, Keating K, Creveling S, et al. Behavioral intervention to improve caloric intake of children with cystic fibrosis treatment versus wait list control. J Pediatr Gastroenterol Nutr 1996 ; 22 : 240-53.
22. 22 Steinkamp G, von Der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr 1994 ; 124 : 244-9.
23. 23 Jelalian E, Stark LJ, Reynolds L, Seifer R. Nutrition intervention for weight gain in cystic fibrosis: a meta analysis. J Pediatr 1998; 132 : 486-92.
24. 24 Gregory PC. Gastrointestinal pH, motility, transit and permability in cystic fibrosis. J Pediatr Gastroenterol Nutr 1996 ; 23 : 513-23.
25. 25 Munck A, Murciano D, Foucaud P, le Bourgeois M, Gerardin M, Aubier M. Effect of renutrition on respiratory muscle function in severe cystic fibrosis [résumé]. In: 19th European cystic fibrosis conference. 1994 juin, Paris.
26. 26 Lester LA, Rothverg RM, Dawson G, Lopez AL, Corpus Z. Supplemental parenteral nutrition in cystic fibrosis. J Parent Enter Nutr 1986 ; 10 : 289-95.